13.000
−3,70%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +30.5% | -11.1% | 1 / 3 | -53.8% | -7.01 pp | +5.55 pp | +10.4% | 0.08 | 7.19 | 30,8 | −53,8% | 2,7 | +30,5% | 7.19 | 8.22 | −12,5% |
| Pts | 8 | 0 | 4 | 0 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-19)EPS (TTM): 1.808
Financial charts
1.Revenue & growth
VND bn30,8Q2/26
1.Revenue & growth
VND bn30,8Q2/26
2.Profit & growth
VND bn2,57Q2/26
3.Profit mix (Penman)
VND bn19,5Q2/26
4.Margins & cost structure
%27.0%Q2/26
5.Returns & cash cycle
% · days5.8%Q2/26
6.Earnings quality & cash
VND bn7,26Q2/26
7.Asset structure
VND bn297Q2/26
8.Funding & debt health
VND bn · times297Q2/26
9.Revenue backlog
VND bn60,6Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %270Q2/26
Adjusted EPS growth, latest quarter
26.3%
Average adjusted EPS growth, 3 quarters
-12.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26